Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Haleon, Pfizer
Why Pfizer sold its $3 billion stake in Haleon
Pfizer’s decision to offload $3.05 billion worth of shares in Haleon is a strategic move driven by shifting priorities in a volatile pharmaceutical market. The transaction, involving 700 million shares priced at 357 pence each,
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Pfizer is looking to sell about 700 million ordinary shares in Haleon , its bookrunner J.P. Morgan said on Tuesday, lowering its stake in the British consumer healthcare company to about 7.3% from 15%.
Pfizer Sells 700 Million Haleon Shares for $3.05 Billion
The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from 15%.
Pfizer Has Sold 700M Haleon Shares
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
3h
EU ‘declares war’ on toxic chemicals: why big pharma and IT giants could flee Ireland for the US
The US could be the beneficiary of a potential blanket ban on the use of PFAS, better known as ‘forever chemicals’.
Hosted on MSN
12h
Pfizer believes in the metaverse: will healthcare thaw the technology’s winter?
The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.
4d
Pfizer going 'all in' on obesity drug development, CEO Bourla says
U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that ...
WBIW
1d
Pharmaceutical companies spike EpiPen prices 600% while allegedly deceiving Hoosier consumers
Attorney General Todd Rokita has filed a lawsuit alleging that Mylan and Pfizer have conspired to increase EpiPen’s price by ...
FiercePharma
3d
JPM25: BMS, Pfizer and Merck CEOs address key patent cliffs and plans to replace sales
Monday, three Big Pharma leaders took center stage and addressed concerns about future patent expirations head-on.
Irish Independent on MSN
2d
Top pharmaceutical and IT companies threaten to quit Ireland if ban on ‘forever chemicals’ is introduced
Leading pharmaceutical and IT companies have said they will quit Ireland if a proposed ban on so-called forever chemicals is ...
BioSpace
3d
Pfizer Cautiously Optimistic on Obesity Pill as Kailera Challenges Lilly’s Zepbound With Strong Phase II Data
Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
FiercePharma
4d
JPM25, Day 1: Pfizer CEO discusses plan to overcome $17B 'LOE wave'
Welcome to day 1 of the J.P. Morgan Healthcare Conference, the industry's most significant dealmaking event each year. | For ...
WDRB
1d
Indiana's attorney general sues 2 pharmaceutical companies over EpiPen costs
The lawsuit filed Thursday in Marion County Superior Court accuses Mylan and Pfizer of conspiring to raise the price of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback